BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37796646)

  • 41. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
    Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies.
    Martella L; Bertozzi S; Londero AP; Steffan A; De Paoli P; Bertola G
    Medicine (Baltimore); 2015 Aug; 94(31):e1113. PubMed ID: 26252272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.
    Kobayashi Y; Shida D; Boku N; Yasui K; Nakamura Y; Kudose Y; Imaizumi J; Kanemitsu Y
    Dis Colon Rectum; 2023 Mar; 66(3):401-409. PubMed ID: 35239524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
    Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
    Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic resection for gastric cancer liver metastases: A systematic review and meta-analysis.
    Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Borgonovo K; Lonati V; Barni S
    J Surg Oncol; 2015 Jun; 111(8):1021-7. PubMed ID: 26082326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
    Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
    Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
    Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
    Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer.
    Duan XF; Dong NN; Zhang T; Li Q
    Int J Clin Oncol; 2013 Feb; 18(1):26-32. PubMed ID: 22041927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression.
    Agboyibor C; Dong J; Effah CY; Drokow EK; Pervaiz W; Li D; Kang L; Ma X; Li J; Liu Z; Liu HM
    Cancer Control; 2021; 28():10732748211051557. PubMed ID: 34802287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    Lambert A; Jarlier M; Gourgou Bourgade S; Conroy T
    PLoS One; 2017; 12(9):e0183288. PubMed ID: 28931010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
    Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
    JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
    Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
    Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Prognostic Value of Patient-Reported Outcome Data in Patients With Colorectal Hepatic Metastases Who Underwent Surgery.
    Rees JR; Rees M; McNair AG; Odondi L; Metcalfe C; John T; Welsh FK; Blazeby JM
    Clin Colorectal Cancer; 2016 Mar; 15(1):74-81.e1. PubMed ID: 26341412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
    Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
    BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    Xu M; Yuan Y; Yan P; Jiang J; Ma P; Niu X; Ma S; Cai H; Yang K
    Clin Breast Cancer; 2020 Aug; 20(4):e385-e396. PubMed ID: 32139270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcomes after different treatments for gastric cancer with synchronous liver metastasis: A PRISMA systematic review and network meta-analysis.
    Li M; Yang B
    Medicine (Baltimore); 2022 Jun; 101(25):e29533. PubMed ID: 35758396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.